Financial terms were not disclosed.Under the agreement, Myriad will use its myChoice HRD Plus test to evaluate patients enrolled in an ongoing Phase III trial. In this collaboration, the companies will use the myChoice HRD […]
Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today announced that eptinezumab, its lead investigational product candidate for migraine prevention targeting calcitonin gene-related peptide (CGRP), […]
Engineered with Flexicon’s trademark precision performance, the PF7 adds a more intuitive, validation-friendly operator interface to reduce the risk of costly filling errors. Precision performance Optimised for precision dispensing by weight or by volume using […]
The Torque platform makes it possible to anchor powerful stimulatory cytokines, antibodies, and small molecules directly to immune cells to direct their activity and increase their efficacy and durability in the “hostile” tumor microenvironment, without […]
Semnur Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company focused on developing and commercializing novel therapeutics for pain, announced the start of a pivotal Phase 3 clinical trial in the U.S. to evaluate its lead […]